Actos News and Research

RSS
Clinical trial finds pioglitazone drug safe and effective for NASH patients

Clinical trial finds pioglitazone drug safe and effective for NASH patients

Takeda Pharmaceutical's $2.37 billion settlement over Actos drug moves forward

Takeda Pharmaceutical's $2.37 billion settlement over Actos drug moves forward

Takeda's $2.37 billion settlement over Actos didn't attract enough claimants to participate in the deal

Takeda's $2.37 billion settlement over Actos didn't attract enough claimants to participate in the deal

Takeda completes post-marketing commitment and data submission for pioglitazone containing medicines

Takeda completes post-marketing commitment and data submission for pioglitazone containing medicines

MT Services reports Actos drug cases, updates settlement news

MT Services reports Actos drug cases, updates settlement news

Single injection of protein FGF1 enough to restore blood sugar levels

Single injection of protein FGF1 enough to restore blood sugar levels

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

First Edition: April 9, 2014

First Edition: April 9, 2014

Takeda expands commercial platform in Israel

Takeda expands commercial platform in Israel

FDA grants final approval to Breckenridge’s Pioglitazone Hydrochloride ANDA

FDA grants final approval to Breckenridge’s Pioglitazone Hydrochloride ANDA

Teva third quarter 2012 net revenues increase 14% to $5.0 billion

Teva third quarter 2012 net revenues increase 14% to $5.0 billion

FDA approves Watson’s generic Actos

FDA approves Watson’s generic Actos

Mylan Pharmaceuticals receives FDA approval for pioglitazone tablets to treat type 2 diabetes

Mylan Pharmaceuticals receives FDA approval for pioglitazone tablets to treat type 2 diabetes

Ranbaxy’s generic pioglitazone hydrochloride tablets now available in the U.S.

Ranbaxy’s generic pioglitazone hydrochloride tablets now available in the U.S.

Study: Diabetes drugs increase patients' risk of bladder cancer

Study: Diabetes drugs increase patients' risk of bladder cancer

Popular class of diabetes drugs increase risk for bladder cancer

Popular class of diabetes drugs increase risk for bladder cancer

Investigational diabetes drug appears to improve insulin sensitivity without side effects

Investigational diabetes drug appears to improve insulin sensitivity without side effects

Scientists identify linchpin of fat metabolism

Scientists identify linchpin of fat metabolism

Physician group touts 'high-value' care

Physician group touts 'high-value' care

First Edition: June 20, 2012

First Edition: June 20, 2012